The Microcirculatory Effects of SANUWAVE, Inc.'s PACE Technology Explained in Presentation by Joanna Cwykiel of Cleveland Clinic

ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc., (OTC BB: SNWV) (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, announced that the cellular and subcellular effects of PACE™ technology were described during a lecture presented this past weekend. Joanna Cwykiel, MSc of Cleveland Clinic conducted the oral presentation titled, Pulsed Acoustic Cellular Expression, at the 10th Annual Wound Healing: Science and Industry conference held December 11th through 13th in St. Thomas, U.S. Virgin Islands.